Lataa...
Poly(ADP‐ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer
BACKGROUND: Ovarian cancer is the sixth most common cancer and seventh most common cause of cancer death in women world‐wide. Three‐quarters of women present when the disease has spread throughout the abdomen (stage III or IV) and treatment consists of a combination of debulking surgery and platinum...
Tallennettuna:
| Julkaisussa: | Cochrane Database Syst Rev |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley & Sons, Ltd
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6457589/ https://ncbi.nlm.nih.gov/pubmed/25991068 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD007929.pub3 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|